Scandinavian Pharmaceuticals ApS: Financial statements 2020
CVR: 41233788
Source: annual report 2020, Danish Business Authority
29/02/2020 – 31/12/2020
Scandinavian Pharmaceuticals ApS (CVR 41233788) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -2,402. Equity in the 2020 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK -2,402
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Official annual report
How creditworthy is Scandinavian Pharmaceuticals ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 8, 2020, Ali Jasim Mohammad Jamil is registered as adm. dir. of Scandinavian Pharmaceuticals ApS.
As of October 8, 2020, Mostafa Abed has stepped down as director of Scandinavian Pharmaceuticals ApS.
As of October 8, 2020, Ali Jasim Mohammad Jamil is registered as an owner of Scandinavian Pharmaceuticals ApS with an ownership share of 100%.
As of February 29, 2020, Mostafa Abed is registered as director of Scandinavian Pharmaceuticals ApS.
Scandinavian Pharmaceuticals ApS was founded on February 29, 2020.
About Scandinavian Pharmaceuticals ApS
Scandinavian Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2020. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Ali Jasim Mohammad Jamil. The company is owned by Ali Jasim Mohammad Jamil. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 40,000.